Strategic partnership Humotech recently announced a Europe-wide strategic partnership with Bio-Connect, expanding access to the Caplex System and mobility technologies. This presents a sales opportunity to align with Bio-Connect’s network to accelerate cross-border adoption and joint marketing of experiential mobility testing solutions.

Expanded capabilities A steady stream of product launches including Caplex EXO-010, PRO-004 Pylon Emulator, CAPLEX EXO family, and child-sized EXO-001 indicates ongoing innovation and a growing product portfolio. Opportunities exist to upsell newer trials and integration services to current clients seeking broader mobility solutions.

Clinical trial focus Caplex System enables real-world trialing of multiple prosthetic feet and mobility technologies without device switching, delivering actionable experiential data. Target hospitals, rehabilitation centers, and research labs prioritizing patient-centered evaluation and evidence-based device selection.

Research collaboration Humotech supports universities, government labs, healthcare organizations, and device manufacturers with wearable robotics platforms for research and development. A pathway exists for contract research, pilot studies, and co-development with institutions seeking advanced mobility testing and data insights.

Global expansion Recent Europe-focused partnership and a scalable Caplex platform suggest readiness for international deployments. Potential sales angles include regional licensing, joint ventures, and localized support services to accelerate adoption in new markets.